Identification |
Name: | 19-Norpregn-4-en-3-one,17-hydroxy-, (17a)- |
Synonyms: | 19-Nor-17a-pregn-4-en-3-one, 17-hydroxy-(8CI); 19-Norandrost-4-en-3-one, 17a-ethyl-17-hydroxy- (6CI); 17-ENT; 17-Ethyl-19-nortestosterone; 17a-Ethyl-17-hydroxy-13b-methylgon-4-en-3-one; 17a-Ethyl-17-hydroxy-19-nor-4-androsten-3-one;17a-Ethyl-17-hydroxy-4-estren-3-one;17a-Ethyl-17-hydroxy-4-norandrosten-3-one;17a-Ethyl-17b-hydroxy-19-norandrost-4-en-3-one;17a-Ethyl-17b-hydroxyestr-4-en-3-one; 17a-Ethyl-19-nortestosterone; 17a-Ethylnortestosterone; 17b-Hydroxy-17a-ethylestr-4-en-3-one;19-Nortestosterone, 17-ethyl-; CB 8022; NSC 70581; NSC 9893; Nileva; Nilevar;Norethandrolone; Pronabol; SC 5914; Solevar; U 6817 |
CAS: | 52-78-8 |
EINECS: | 200-153-5 |
Molecular Formula: | C20H30 O2 |
Molecular Weight: | 302.50 |
InChI: | InChI=1/C20H30O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h12,15-18,22H,3-11H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 130-136 oC |
Density: | 1.1g/cm3 |
Refractive index: | 1.555 |
Report: |
EPA Genetic Toxicology Program.
|
Safety Data |
|
|